drugset / Trial / NCT04142970
Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions
Phase 1
Completed
24 enrolled
Sichuan Haisco Pharmaceutical Group Co., Ltd
The First Affiliated Hospital of Zhengzhou University · collab
Non-randomizedSequentialOpen-labelOther
Summary
A Clinical Study Comparatively Evaluating the Pharmacokinetics, Pharmacodynamics and Safety of Intravenous Administration of HSK3486 Injectable Emulsion in Patients with Chronic Renal Impairment and Subjects with Normal Renal Functions
Timeline
- Start
- 2020-01-05
- Primary completion
- 2020-08-04
- Completion
- 2020-08-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cipepofol | Small molecule | 0.4 mg/kg | Intravenous |